Wolverine Trading, LLC Supernus Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$23.54 - $31.39 $157,718 - $210,313
-6,700 Closed
0 $0
Q2 2021

Aug 06, 2021
SELL
$26.72 - $33.19 $454,240 - $564,230
-17,000 Reduced 71.73%
6,700 $212,000
Q1 2021

May 14, 2021
BUY
$24.15 - $31.45 $572,355 - $745,365
23,700 New
23,700 $620,000
Q2 2020

Aug 13, 2020
SELL
$17.09 - $24.89 $217,043 - $316,103
-12,700 Closed
0 $0
Q1 2020

May 11, 2020
SELL
$14.45 - $24.69 $216,750 - $370,350
-15,000 Reduced 54.15%
12,700 $218,000
Q4 2019

Feb 12, 2020
BUY
$19.93 - $29.13 $127,552 - $186,432
6,400 Added 30.05%
27,700 $647,000
Q3 2019

Nov 14, 2019
BUY
$25.47 - $33.37 $165,555 - $216,904
6,500 Added 43.92%
21,300 $585,000
Q2 2019

Aug 20, 2019
SELL
$29.96 - $38.87 $635,152 - $824,044
-21,200 Reduced 58.89%
14,800 $490,000
Q1 2019

May 15, 2019
BUY
$32.77 - $41.99 $265,437 - $340,119
8,100 Added 29.03%
36,000 $1.26 Million
Q4 2018

Feb 14, 2019
SELL
$30.84 - $49.51 $493,440 - $792,160
-16,000 Reduced 36.45%
27,900 $903,000
Q3 2018

Nov 14, 2018
BUY
$42.7 - $56.55 $807,030 - $1.07 Million
18,900 Added 75.6%
43,900 $2.21 Million
Q1 2018

May 15, 2018
BUY
$37.15 - $46.9 $928,750 - $1.17 Million
25,000 New
25,000 $1.15 Million

Others Institutions Holding SUPN

# of Institutions
283
Shares Held
60.5M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.09B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email